Clinical trials
2 active studies led by Enbiosis Biotechnologies, of 2 in all
Source: ClinicalTrials.gov, Studies with Enbiosis Biotechnologies (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public records show Enbiosis Biotechnologies in 1 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Enbiosis Biotechnologies or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
2 active studies led by Enbiosis Biotechnologies, of 2 in all
Source: ClinicalTrials.gov, Studies with Enbiosis Biotechnologies (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Markets we cover where free public records show Enbiosis Biotechnologies: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Enbiosis Biotechnologies is in.
Stories on the topics Enbiosis Biotechnologies works in.
More than 90% of US women and 97% of men do not eat enough fibre. Prebiotics are the fibres that feed helpful…
Read
Gut health is one of the biggest wellness trends. Probiotics help in some cases, but not all products or…
Read
WHO says only about half of patients in developed countries take long-term medicines as prescribed. Patient…
ReadSearch all reports for Enbiosis Biotechnologies All companies